NanoMosaic
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
12 Gill St Ste 4200, Woburn, Massachuset...Phone Number
(617) 925-7771Website
www.nanomosaicllc.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About NanoMosaic
NanoMosaic, a Boston-based biotechnology company, is the first commercial entity to leverage the power of nanoneedles for protein detection and quantification to develop best-in-class assays for biomarker discovery and validation. The NanoMosaic platform, Tessie, enables coverage of the largest dynamic range while maintaining high sensitivity, multiplexing capabilities and label-free assays. With 1.8 billion MosaicNeedles (each equating to a landing site for a protein, resulting in a read) on its current chip format, the NanoMosaic chip enables full proteome interrogation at 7 orders of dynamic range and is able to attain multiplexing levels in the thousands per chip. The proprietary technology enables rapid custom assay development with varying levels of concentrations on a single chip to develop novel biomarkers and push the frontier of the biomarker discovery and diagnostics space.Explore more
NanoMosaic Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NanoMosaic your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if NanoMosaic is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
NanoMosaic, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once NanoMosaic has new funding data
Congratulate Masked Content for being promoted to Masked Content at NanoMosaic
Website visits: Recent activity has been detected on your website
Click to see if NanoMosaic had a recent Job posting/layoffs
Earning: See what the market has to say on NanoMosaic recently announced quarterly report
Check if NanoMosaic has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when NanoMosaic launches new products
Recommended Actions
Reach out to Masked Content who joined NanoMosaic as Masked Content
Find 2 more new buyers
Compare Similar Companies to NanoMosaic
Compare insights from companies similar to NanoMosaic, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
NanoMosaic is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
NanoMosaic is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about NanoMosaic.
NanoMosaic financials insights
Gather financial insights about NanoMosaic, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Angel/Seed
$2M
Series A
$40.8M
NanoMosaic Tech Stack
A closer look at the technologies used by NanoMosaic
Most Recent Scoops
Event
Product Marketing, Events, Sales, Search, Laboratory Operations, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations
New Hire
Executive Move
Lateral Move
Executive Move
Board of Directors
Lateral Move
Executive Move
Open Position
Executive Move
NanoMosaic News & Media
NanoMosaic Appoints Dr. Anne Marie Morse as Chairwoman of Newly Formed Clinical Advisory Board
Expanded clinical leadership accelerates clinical diagnostics and neurological applications for companion diagnostics (CDx) and "Brain Health" BOSTON, Jan. 6, 2026 /PRNewswire/ -- NanoMosaic, Inc. today announced the appointment of Dr. Anne Marie Morse, an internationally recognized...NanoMosaic Transforms Cell and Gene Therapy Analytics with Advanced Quantification and Genome Mapping Capabilities. World-Renowned Expert Dr. Guangping Gao to Join Nanomosaic Scientific Advisory Board
WALTHAM, Mass., Sept. 24, 2024 /PRNewswire/ -- Nanomosaic, the multiplex and multi-omic marker analysis company, today announced major technical and commercial milestones for its Tessie system and assays optimized for gene therapy applications, evidencing the need for improved analytics...NanoMosaic launches AAV gene therapy bioprocessing and manufacturing QC assays for simultaneous capsid & transgene interrogation with high standardization
WALTHAM, Mass., March 6, 2024 /PRNewswire/ -- NanoMosaic, the multiplex and multi-omic quantification company, today announced the expanded capabilities and availability of assays optimized on its Tessie™ system for use in gene therapy applications. The platform combines the ability to...Leadership Evolution at NanoMosaic: The Company Welcomes Philippe Mourere as CEO, John Boyce Assumes the Role of Executive Chairman, and Appoints Joe Wilkinson as President and COO
WALTHAM, Mass., Dec. 7, 2023 /PRNewswire/ -- NanoMosaic, the trailblazing company in the realm of true multi-omic analysis, announces a strategic shift in its leadership team with the appointment of John Boyce as Executive Chairman, Philippe Mourere as Chief Executive Officer, and Joe...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NanoMosaic
Sign Up For FreeTo access detailed company insights
NanoMosaic, a Boston-based biotechnology company, is the first commercial entity to leverage the power of nanoneedles for protein detection and quantification to develop best-in-class assays for biomarker discovery and validation. The NanoMosaic platform, Tessie, enables coverage of the largest dynamic range while maintaining high sensitivity, mult... Read More
